Related references
Note: Only part of the references are listed.The Pathogenesis of HIV-Associated Nephropathy
Lewis Kaufman et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2010)
Myocardial infarction risk in HIV-infected patients: epidemiology, pathogenesis, and clinical management
Leonardo Calza et al.
AIDS (2010)
Causes of Death in HIV-1-Infected Patients Treated with Antiretroviral Therapy, 1996-2006: Collaborative Analysis of 13 HIV Cohort Studies
John Gill et al.
CLINICAL INFECTIOUS DISEASES (2010)
Estimating the Optimal CD4 Count for HIV-infected Persons to Start Antiretroviral Therapy
Bryan E. Shepherd et al.
EPIDEMIOLOGY (2010)
Analysis of serious non-AIDS events among HIV-infected adults at Latin American sites
W. H. Belloso et al.
HIV MEDICINE (2010)
Genetics of Focal Segmental Glomerulosclerosis and Human Immunodeficiency Virus-Associated Collapsing Glomerulopathy: The Role of MYH9 Genetic Variation
Cheryl A. Winkler et al.
SEMINARS IN NEPHROLOGY (2010)
Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study
Nancy Crum-Cianflone et al.
AIDS (2009)
Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalite 2005 study
Dominique Salmon-Ceron et al.
JOURNAL OF HEPATOLOGY (2009)
Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans
Barry I. Freedman et al.
KIDNEY INTERNATIONAL (2009)
Hepatitis B and C virus co-infection in Nigerian patients with HIV infection
Olanisun Olufemi Adewole et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2009)
HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity
Steven G. Deeks et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia
Lloyd B. Mulenga et al.
AIDS (2008)
Predictors of renal outcome in HIV-associated nephropathy
Frank A. Post et al.
CLINICAL INFECTIOUS DISEASES (2008)
MYH9 is associated with nondiabetic end-stage renal disease in African Americans
W. H. Linda Kao et al.
NATURE GENETICS (2008)
Presentation and outcome of hepatocellular carcinoma in HIV-infected patients:: A US-Canadian multicenter study
Norbert Braeu et al.
JOURNAL OF HEPATOLOGY (2007)
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
Andrew E. Grulich et al.
LANCET (2007)
Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease
Virginia A. Triant et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Ischemic heart disease in HIV-infected and HIV-uninfected individuals: A population-based cohort study
Niels Obel et al.
CLINICAL INFECTIOUS DISEASES (2007)
Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area
E. Martinez et al.
HIV MEDICINE (2007)
Serological evidence of HIV-associated infection among HIV-1-infected adults in Botswana
C. William Wester et al.
CLINICAL INFECTIOUS DISEASES (2006)
Mortality in the highly active antiretroviral therapy era - Changing causes of death and disease in the HIV outpatient study
Frank J. Palella et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy
J Röling et al.
CLINICAL INFECTIOUS DISEASES (2006)
C-reactive protein is a marker for human immunodeficiency virus disease progression
B Lau et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Correlation between reduction in plasma HIV-1 RNA concentration 1 week after start of antiretroviral treatment and longer-term efficacy
MA Polis et al.
LANCET (2001)
Share Paper
